Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003748243 | SCV004538838 | pathogenic | Jeune thoracic dystrophy | 2024-01-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gly2684*) in the DYNC2H1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYNC2H1 are known to be pathogenic (PMID: 23339108, 32753734, 33755199). This variant is present in population databases (rs747857715, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with clinical features of DYNC2H1-related conditions (PMID: 29068549). ClinVar contains an entry for this variant (Variation ID: 446607). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV001291289 | SCV005678335 | likely pathogenic | Asphyxiating thoracic dystrophy 3 | 2024-05-08 | criteria provided, single submitter | clinical testing | |
Dan Cohn Lab, |
RCV001291289 | SCV000612008 | pathogenic | Asphyxiating thoracic dystrophy 3 | 2017-06-01 | no assertion criteria provided | research | |
University of Washington Center for Mendelian Genomics, |
RCV001291289 | SCV001479742 | likely pathogenic | Asphyxiating thoracic dystrophy 3 | no assertion criteria provided | research |